IFNAR1 and Alzheimer disease: Accordingly, blockade or ablation of the receptor for type I IFN (IFNAR) abolished the upregulation of IFN-responsive genes in aging or AD mouse models [96, 98, 99], diminished microgliosis and synapse loss in AD models [95], and partially reduced age-related cognitive decline [99].